U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07941505) titled 'Low-Dose IV Buprenorphine vs Hydromorphone for Acute Pain in the ED' on Nov. 10.
Brief Summary: The goal of this study is to compare low-dose IV buprenorphine with IV hydromorphone for adults with undifferentiated acute pain in the Stanford Emergency Department.
Study Start Date: July, 2027
Study Type: INTERVENTIONAL
Condition:
Acute Pain
Intervention:
DRUG: Buprenorphine (BUP)
Buprenorphine is a partial mu-opioid receptor agonist with a ceiling effect on respiratory depression and a longer duration of action than full agonists.
DRUG: Hydromorphone
Hydromorphone is a full mu-opioid receptor agonist and a commonly used stand...